77 A new global study, published in the Journal of Hematology & Oncology, has revealed a sharp rise in the burden of female-specific cancers over the past three decades, with breast cancer now accounting for the highest number of cases worldwide. The findings, drawn from data spanning 1990 to 2021, indicate significant disparities in cancer incidence and mortality, largely influenced by economic development and access to healthcare. According to the study, breast cancer remains the most commonly diagnosed cancer in women, with more than two million new cases recorded in 2021 alone. While its incidence is highest in high-income countries, driven by lifestyle factors and improved screening, low- and middle-income nations are also experiencing a surge. In contrast, cervical cancer, which remains the leading cause of cancer-related deaths among women in many lower-income regions, has seen a decline in incidence in wealthier countries due to the widespread adoption of HPV vaccination and improved screening programmes. The research highlights that ovarian and uterine cancers are also on the rise, with uterine cancer particularly increasing in high-income nations. Experts suggest that rising obesity rates, changes in reproductive patterns, and ageing populations may be contributing factors. In contrast, ovarian cancer, while still carrying a high mortality rate, has shown slight declines in some developed regions, attributed to advances in early detection and treatment strategies. One of the most striking aspects of the study is the clear correlation between cancer incidence and a country’s level of socioeconomic development. While breast, ovarian, and uterine cancers are more common in high-income countries, cervical cancer remains disproportionately prevalent in low-income regions where access to vaccination, screening, and timely treatment is often limited. This divide underscores the ongoing challenges in addressing global cancer inequality, with resource-limited settings facing a higher mortality burden despite medical advances elsewhere. In addition to the epidemiological trends, the study identifies key risk factors contributing to female-specific cancers. High body mass index, alcohol consumption, and physical inactivity were found to be significant contributors to breast cancer risk, while tobacco use and unsafe sexual practices were linked to cervical cancer. Occupational exposures and obesity were associated with ovarian and uterine cancers, further highlighting the role of modifiable lifestyle factors in cancer prevention. The findings reinforce the urgent need for targeted public health interventions tailored to different regions. In high-income countries, increasing emphasis on lifestyle changes, early detection, and improved treatment options is essential, while in low-income regions, expanding vaccination coverage and improving access to screening could help reduce preventable deaths. Policymakers are encouraged to address the disparities by ensuring equitable healthcare access and strengthening cancer prevention strategies across all socioeconomic levels. As cancer rates continue to rise globally, the study serves as a reminder that while medical advancements have improved outcomes in many parts of the world, significant gaps remain. Without concerted efforts to close these disparities, the burden of female-specific cancers is likely to increase, placing further strain on healthcare systems worldwide.